The global iot medical devices market size was valued at USD 25.97 billion in 2025 and is projected to grow from USD 33.14 billion in 2026 to USD 232.88 billion by 2034, registering a CAGR of 27.6% during the forecast period from 2026 to 2034. North America dominated the iot medical devices market with a market share of 39.8% in 2025.
IoT medical devices are connected healthcare devices that use internet-enabled technologies to collect, transmit, and exchange patient or medical data. These devices include wearable monitors, smart sensors, connected diagnostic equipment, and remote patient monitoring systems. They support real-time health tracking, remote care, automated data collection, clinical decision-making, and improved communication between patients, healthcare providers, and medical facilities.
Download a Free Sample To learn more about this report,
AI Is Turning Connected Medical Devices into Predictive Clinical Tools
Advances in machine learning and the availability of continuous patient data are shifting connected medical devices from basic monitoring toward predictive clinical support. The FDA reported more than 1,600 AI-enabled medical devices authorized in the U.S. as of September 2026, including devices that detect disease, estimate cardiac risk, and automate insulin dosing. This transition enables earlier identification of clinical changes, supports more personalized interventions, and increases the clinical value of connected medical devices.
Medical Device Interoperability Is Moving Toward Standards-Based Connectivity
The need for seamless data exchange among medical devices, healthcare systems, and clinical platforms is shifting connected devices toward standards-based interoperability. The FDA recognizes standards such as IEEE 11073 and ANSI/AAMI/UL 2800 to support safe and secure information exchange and integration among interoperable medical devices. This transition improves device compatibility, reduces isolated data systems, and supports broader deployment of connected medical devices across healthcare facilities.
Expansion of Remote Patient Monitoring and Hospital Asset Tracking Needs for IoT-Enabled Equipment Drive Market
Remote patient monitoring is shifting routine care from periodic clinical visits toward continuous observation outside traditional healthcare facilities. This transition is increasing the use of connected blood pressure monitors, glucose meters, pulse oximeters, and wearable devices that transmit patient data to healthcare providers. The outcome is greater demand for IoT-enabled monitoring devices as healthcare systems expand remote-care services, with WHO recognizing remote monitoring as an important component of telehealth and digitally enabled care.
Hospital asset management is moving from manual equipment searches toward connected tracking of medical devices, beds, and other mobile resources. This transition gives healthcare teams better visibility of equipment location and availability, which supports more efficient utilization and reduces time spent locating critical assets. The outcome is expanding demand for IoT tags, sensors, and tracking platforms, while WHO guidance highlights inventory and maintenance management as important for the availability and proper management of medical devices.
High Cost of IoT-Enabled Medical Devices and Complexity of Device Integration With Hospital Systems Restrain Market Expansion
High costs of IoT-enabled medical devices can limit adoption because connected equipment often requires additional sensors, software, connectivity infrastructure, and supporting systems. Healthcare providers with constrained budgets may postpone upgrades or prioritize essential medical equipment over connected solutions. These financial barriers can slow deployment and restrict market penetration, particularly among smaller healthcare facilities.
Complex integration requirements can delay IoT medical device adoption when new connected devices must work with existing hospital information systems and clinical workflows. Differences in software platforms, data formats, and communication standards can increase implementation time and require additional technical resources. These integration barriers can slow deployment, increase project costs, and limit the pace of market expansion
IoT-Based Medication Adherence and Connected Cold Chain Monitoring Offers Growth Opportunities
Patients managing chronic therapies, caregivers, pharmacies, and healthcare providers can use smart dispensers, connected packaging, and reminder systems to support medication adherence. These solutions create revenue through connected devices, monitoring platforms, software subscriptions, and adherence services. Companies such as MedMinder and Hero Health operate connected medication-management solutions.
Pharmaceutical manufacturers, hospitals, laboratories, distributors, and logistics providers can use connected sensors to monitor temperature and environmental conditions during storage and transportation. IoT providers can generate recurring revenue through sensors, cloud monitoring platforms, analytics, and managed monitoring services. Companies such as DHL and Tive provide connected shipment-monitoring solutions relevant to this opportunity.
Regulatory Complexity for Connected Medical Devices and Rapid Technology Obsolescence Hinders Market Growth
IoT medical devices combine hardware, software, connectivity, and clinical functions, creating complex regulatory requirements across different markets. Changing standards and requirements can extend product development and approval timelines, increasing uncertainty for companies launching new connected devices.
Fast advances in sensors, connectivity standards, cloud platforms, and device capabilities can shorten product lifecycles and increase pressure on manufacturers to continuously upgrade their portfolios. Frequent technology changes can complicate long-term product planning and reduce the commercial lifespan of existing IoT medical devices.
The medical devices segment dominated the market with a market share of 42.5% in 2025, reflecting the broad use of medical devices across connected healthcare, monitoring, diagnosis, and treatment. Wearable external devices segment, systems & software segment, and services segment also represent important components, while implanted medical devices segment, stationary medical devices segment, and connectivity technology segment support specific healthcare requirements.
The wearable external devices segment is expected to grow at the fastest CAGR of 24.6% during the forecast period 2026–2034, supported by increasing adoption of devices that enable continuous health monitoring and data collection. Medical devices segment, systems & software segment, services segment, implanted medical devices segment, stationary medical devices segment, and connectivity technology segment continue to support the broader connected healthcare ecosystem.
Request Customizationto receive a tailored report.
The telemedicine segment dominated the market with a market share of 28.4% in 2025 and is also expected to grow at the fastest CAGR of 24.3% during the forecast period 2026–2034, supported by the increasing adoption of remote consultations and digitally enabled healthcare services.
Workflow management segment, connected imaging segment, inpatient monitoring segment, medication management segment, and others segment continue to support digital healthcare delivery across clinical, operational, diagnostic, and patient-care functions.
The hospitals segment dominated the market with a market share of 47.3% in 2025, supported by the widespread use of healthcare technologies across diagnosis, treatment, monitoring, and clinical management. Surgical centers and clinics segment, clinical research organizations (CROs) segment, and research and diagnostic laboratories segment also represent important end-user groups.
The clinical research organizations (CROs) segment is expected to grow at the fastest CAGR of 23.1% during the forecast period 2026–2034, supported by the use of digital healthcare technologies in clinical research and related activities. Hospitals segment, surgical centers and clinics segment, and research and diagnostic laboratories segment continue to support healthcare delivery, research, and diagnostic services.
Speak to an Analystto discuss market opportunities.
North America held the largest share of the IoT medical devices market at 39.8% in 2025, supported by the region’s established healthcare infrastructure, strong adoption of connected medical technologies, and widespread use of digital healthcare solutions. The U.S. IoT medical devices market is supported by the continued expansion of remote patient monitoring, with Medicare covering connected devices that collect and transmit physiological data such as blood pressure, glucose, oxygen saturation, and weight for eligible patients.
The Canada IoT medical devices market is expected to see greater demand for connected monitoring technologies as Statistics Canada projects the population aged 85 and over to increase from 951,833 in 2025 to between 3.3 million and 4.2 million by 2075, increasing the need for ongoing health monitoring and care services
Unlock Regional Insightsto access country-level data, & regional trends.
Asia Pacific is projected to record the fastest growth in the IoT medical devices market, with a CAGR of 24.7% during the forecast period, driven by expanding healthcare digitization, rising demand for remote monitoring, and increasing adoption of connected medical devices. The Japan IoT medical devices market is expected to benefit from increasing healthcare requirements among older adults, with Japan’s Ministry of Health, Labour and Welfare projecting that people aged 65 and over will represent about 35% of the population by 2040.
The China IoT medical devices market is supported by the Healthy China 2030 framework, which promotes internet-based healthcare, wearable devices, smart health electronics, mobile health applications, and the development of smart healthcare technologies through 2030. The South Korea IoT medical devices market is expected to benefit from the country’s Health Plan 2030, which targets an increase in healthy life expectancy from 70.4 years in 2018 to 73.3 years by 2030 while strengthening long-term health and disease-prevention initiatives. The India IoT medical devices market is supported by the expansion of the Ayushman Bharat Digital Mission, which had created more than 722 million ABHA health accounts and linked over 471 million health records by December 2024, strengthening the digital infrastructure needed for connected healthcare technologies.
Europe accounted for 27.4% of the IoT medical devices market in 2025 and is expected to grow at a CAGR of 19.8%, supported by the continued integration of connected technologies into healthcare systems and growing use of smart medical devices. The U.K. IoT medical devices market is supported by population ageing, with the Office for National Statistics projecting the number of people aged 85 and over to reach 3.5 million by 2035, more than double the level recorded in 2010.
The Germany IoT medical devices market is likely to benefit from rising healthcare needs among older adults, as Destatis projects that one in four people will be aged 67 or older by 2035, compared with one in five in 2024. The France IoT medical devices market is expected to gain from demographic ageing, with INSEE projecting that people aged 75 and over will account for 14.8% of the population by 2040, compared with 12.3% in 2030.
The IoT medical devices market is highly fragmented, with competition comprising established medical device manufacturers, healthcare technology companies, specialized IoT solution providers, software and connectivity companies, and emerging medtech firms. The leading players in the IoT Healthcare Market are Medtronic, Royal Philips, GE Healthcare, Cisco Systems Inc., and IBM Corporation, with these five companies collectively estimated to account for approximately 10% of the global IoT healthcare market share.
Established players compete primarily through broad connected-device portfolios, product reliability, regulatory compliance, data security, interoperability, clinical validation, and established healthcare partnerships. Emerging players in the IoT medical devices market ecosystem compete through AI-enabled monitoring, remote patient care, wearable technologies, real-time analytics, cloud-based platforms, and specialized solutions for specific clinical needs. Competitive differentiation also depends on integration capabilities, ease of deployment, scalability, patient engagement, and the ability to connect medical devices with broader healthcare information systems.
Customize This Report to Match Your Strategic Objectives
Author's Details
Healthcare Lead
Debashree Bora is a strategic healthcare research professional with nearly eight years of hands on experience in market intelligence, encompassing primary research, secondary research, market estimation, and consulting engagements. She specializes in pharmaceutical, biotechnology, medical devices, healthcare services, clinical trials, and healthcare outsourcing sectors, providing actionable insights on evolving industry trends, regulatory landscapes, competitive dynamics, and market opportunities. Debashree’s research helps global clients evaluate market potential, identify growth opportunities, strengthen commercial strategies, and make informed business decisions.
Ai Based Clinical Trials Solution Provider Market Size, 2034
Digital Pathology Market Size, Share, Growth, Forecast, 2034
Digital Pills Market Size, Share, Growth, Analysis, Report, 2034
Healthcare Supply Chain Market Size, Share, Growth, Analysis, 2034
Clinical Trial Management System Market Size, Share, Growth, 2034
Biohacking Market Size, Share, Growth, Analysis, Report, 2034
We are featured on:
sales@straitsresearch.com